Madrigal Pharmaceuticals receives three new resmetirom patents
Go back to Madrigal Pharmaceuticals receives three new resmetirom patents| (NASDAQ: MDGL) | Delayed: 546.66 +12.50 (2.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $534.16 | 52 Week High | $18.24 | |||
| Open | $529.50 | 52 Week Low | $6.60 | |||
| Day High | $549.97 | P/E | N/A | |||
| Day Low | $526.88 | EPS | $0.00 | |||
| Volume | 281,256 | |||||

